Global Spirometer Market

Spirometer Market Size, Share, Growth Analysis, By Type(Handheld, and Tabletop), By Technology(Volume Measurement, Flow Measurement), By Application(Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Pulmonary Fibrosis), By End User(Hospitals and Clinics, Diagnostic Laboratories, Home Healthcare, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2503 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 92 | Figures: 76

Spirometer Market Insights

Spirometer Market size was valued at USD 951.0 million in 2022 and is poised to grow from USD 1036.3 million in 2023 to USD 1989.1 million by 2031, growing at a CAGR of 8.52% in the forecast period (2024-2031). 

An increase in the number of chronic respiratory diseases, a change in preferences for home care and new technologies are expected to boost the growth of the market. WHO estimates that 90% of the global population breathe poor air quality that contains pollutants and irritants that impact lungs in several ways.  

The spirometry equipment helps identify respiratory diseases such as obstructive chronic lung disease, emphysema, asthma and other lung diseases in an occupational environment. The rising incidence and prevalence rates of COPD in the global population also mean that the screening of COPD condition will be required, which will propel the need for spirometry tests. For instance, in November 2021, in the European Respiratory Journal, the authors pointed out that it is predicted that 49,453,852 Europeans will have COPD in 2050, while in 2020, it was 36,580,965. In addition, Netherlands also expected to have the highest incidence of COPD at 14.6%. Furthermore, research carried out in January 2021 and published in PLOS ONE found that in France, 2.6 million Chronic obstructive pulmonary disease affects people with a projection to reach 2.8 million by 2025. Hence, the continuously rising number of COPD patients will strengthen the need for technologically advanced spirometers, which will further boost the market growth. 

Another factor is the increasing number of active ageing because they need the products offered by the markets most of the time. This demographic group is more vulnerable to chronic respiratory conditions and spirometry serves to diagnose them. Also, raising the popularity of enhanced diagnostic procedures among consumers is also promoting market growth. There are many new technologies which have facilitated the clinicians and hospitals to monitor patient data easily; this includes advancements in the design of spirometers which are now small and portable and can be connected to smart devices. Moreover, the development of new products with greater efficiency also boosts the research and development activities to drive the market.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Spirometer Market size was valued at USD 951.0 million in 2022 and is poised to grow from USD 1036.3 million in 2023 to USD 1989.1 million by 2031, growing at a CAGR of 8.52% in the forecast period (2024-2031). 

The market is competitive and driven by technological factors and the expansion strategies implemented in the markets. Businesses are concerned with the improvement of spirometry tools to increase precision, ease of use, and patient tolerance. New entrants are gradually increasing their presence with niche products and partnerships. This category of strategies entails forming partnerships, mergers, and acquisitions to enhance market position and leverage the increasing demand for respiratory diagnostic solutions in the global market. 'Baxter International Inc (US)  ', 'Midmark Corporation (US) ', 'FutureMed (US) ', 'COSMED SRL (Italy) ', 'MGC Diagnostics Corporation (US) ', 'Medical International Research (MIR) (Italy) ', 'Vyaire Medical Inc (US) ', 'Vitalograph (UK) ', 'NDD Medical Technologies Inc (Switzerland) ', 'Schiller AG (Switzerland) ', 'Jones Medical Instrument Company (US) ', 'Sibelmed (Spain) ', 'Medline Industries LP (US) ', 'NCE Empowering Safety (US) ', 'Teleflex Inc (US) ', 'The Contec Group (China) ', 'Medikro (Finland) ', 'SDI Diagnostics (US) ', 'Chest M.I., Inc (Japan) ', 'Fukuda Sangyo Co. Ltd., (Japan)'

The spirometers are demanding for early detection, disease management, and treatment intervention for people with respiratory disorders. In 2020, the COPD incidence was estimated 10.6% in both males and females, equivalent to 480 million cases. The estimates of COPD prevalence suggest that the figure of COPD patients will increase by 112 million by 2050, totaling 592 million or 9.3% from year 2020 to year 2050. This rising is mainly due to the increasing prevalence of COPD among female patients and LMICs. In females, COPD is expected to rise to 7.8% in 2020 to 8.3% in 2050. The number of the population aged 65 and over was 8% in 2020 and 8.3% in 2050, a relative increase of 6.4%. The global prevalence of COPD in females is projected to rise from 177 million in the year 2020 to 260 million by the year 2050, this a rise of 83 million, 47.1% relative increase. 

Advancements in spirometry technology: The development of new spirometry devices is now experiencing fast-growing demand in the global market due to better usability, portability, and cheaper prices. Some of the advancements include portable devices that have greatly enhanced respiratory care through enhanced portability and convenience of the devices to both the carers and the patients. These portable equipments allow pulmonary function tests in non-hospital environments, particularly in point-of-care and telemedicine settings. For instance, in January 2024, the Air Next spirometer developed by NuvoAir is a breakthrough, as it is the first spirometer approved by the FDA for home use. Moreover, incorporation with Smartphones has emerged as a trend that utilizes the existing popular devices to improve usability. spirometers are integrated with smartphone applications, which track patients’ respiratory health and share the data with their healthcare providers for assessment and management without physically visiting the clinic. 

North America held the largest market share in 2023 with 38.04% due to increasing incidences of respiratory diseases. Asthma and COPD incidence has led to higher spirometer sales because of disease necessity and acceptance among hospital doctors. Also, the United States has been at the forefront of embracing technologies to reduce the incidences of COPD. Such factors indicate that the market has good potential for growth in the future for the given forecast period. Chronic respiratory diseases are prevalent in the United States, which increases the need to monitor the conditions through portable handheld spirometers. 

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Spirometer Market

Report ID: SQMIG35A2503

$5,300
BUY NOW GET FREE SAMPLE